23 July 2019
LEI No. 213800QIPVTK5ES5UU36
Scapa Group plc
('Scapa' or 'the Company')
Result of AGM
Scapa Group plc (AIM: SCPA) is pleased to announce that all resolutions proposed at its Annual General Meeting held on 23 July 2019 were duly passed by shareholders on a poll. The poll votes on each resolution proposed are set out below:-
|
Resolution |
For |
Against |
Withheld |
|
1 To receive the Accounts and Reports of the Directors and Auditors for the year ended 31 March 2019 |
100,106,116 100%* |
0 0.00%* |
76,750 |
|
2 To approve the Directors' Remuneration Report (excluding the Directors' Remuneration Policy) for the financial year ended 31 March 2019. |
85,747,141 85.85%* |
14,131,980 14.15%* |
303,745 |
|
3 To approve the Directors' Remuneration Policy for the financial year ended 31 March 2019. |
98,390,796 98.22%* |
1,787,365 1.78%* |
4,705 |
|
4 To declare a final dividend of 2.9p per ordinary share |
100,180,981 100%* |
0 0.00%* |
1,885 |
|
5 To re-elect Larry Pentz as a Director |
98,349,198 99.13%* |
864,689 0.87%* |
968,979 |
|
6 To re-elect Heejae Chae as a Director |
100,016,778 99.84%* |
162,703 0.16%* |
3,385 |
|
7 To re-elect David Blackwood as a Director |
99,900,151 99.72%* |
279,330 0.28%* |
3,385 |
|
8 To re-elect Pierre Guyot as a Director |
99,915,069 99.74%* |
264,412 0.26%* |
3,385 |
|
9 To re-elect Brendan McAtamney as a Director |
99,915,069 99.74%* |
264,412 0.26%* |
3,385 |
|
10 To elect Oskar Zahn as a Director |
99,562,291 99.38%* |
618,704 0.62%* |
1,871 |
|
11 To elect Sevan Demirdogen as a Director |
100,018,292 99.84%* |
162,703 0.16%* |
1,871 |
|
12 To elect Joseph Doherty as a Director |
100,018,292 99.84%* |
162,703 0.16%* |
1,871 |
|
13 RESOLUTION WITHDRAWN |
|||
|
14 To reappoint Deloitte LLP as auditor of the Company |
99,273,495 99.39%* |
607,140 0.61%* |
302,231 |
|
15 To authorise the Directors to fix the remuneration of the auditor |
100,107,256 99.93%* |
74,879 0.07%* |
731 |
|
16 That the rules of the Scapa Group plc 2019 Long Term Incentive Plan are approved
|
98,502,321 98.32%* |
1,678,685 1.68%* |
1,860 |
|
17 To authorise the Company to make political donations |
98,529,711 98.35%* |
1,651,295 1.65%* |
1,860 |
|
18 To authorise the Directors to allot shares |
93,047,128 92.88%* |
7,128,878 7.12%* |
6,860 |
|
19 To authorise the Directors to dis-apply pre-emption rights in relation to the customary 5% power pursuant to the statement of principles dis-applying pre-emption rights |
100,174,274 100%*
|
1,361 0.00%* |
7,231 |
|
20 To authorise the Directors to dis-apply pre-emption rights in relation to the additional 5% power to be used in connection with an acquisition or a specified capital investment |
99,288,893 99.12%* |
885,782 0.88%* |
8,191 |
|
21 To authorise the Company to make market purchases of its own shares |
99,867,159 99.70%* |
300,401 0.30%* |
15,306 |
* as a percentage of votes cast
For further information:
|
Scapa Group plc: |
|
|
Wendy Baker Company Secretary |
+44 (0) 161 301 7400 |
|
Numis Securities Limited: |
|
|
Mark Lander/Richard Thomas (Joint Broker/Nominated Adviser) |
+44 (0) 20 7260 1000 |
About Scapa Group plc
Scapa Group plc is a diversified Healthcare and Industrial company focused on bringing best-in-class innovation, design and manufacturing solutions to its customers.
Healthcare
Scapa Healthcare is the trusted strategic partner of choice for the world's leading companies in Advanced Wound Care, Consumer Wellness and Medical Device Fixation. We partner with the top global MedTech companies to develop and manufacture innovative skin friendly medical device fixation and topical solutions, from inception through to market delivery, from our state-of-the-art facilities.
For further information, please visit www.scapahealthcare.com
Industrial
Scapa Industrial is a global supplier of bonding solutions and manufacturer of adhesive-based products which offer meaningful value in industrial applications due to their lightweight, easy-to-apply properties. We are recognised for our unparalleled range of products, including adhesive tapes, films and foams, and we can engineer custom designs for even the most unique applications.
For further information, please visit www.scapaindustrial.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
